
Emily Field
Emily Field is a prominent analyst in the pharmaceutical sector, currently leading European pharmaceutical research at Barclays. She has recently gained attention for her insights into the potential impacts of trade tariffs on prescription drug prices, as well as her interactions with clients concerned about the implications of U.S. trade policies under President Trump's administration.
Not in the pool (under ¢1).
Recent news mentions
Analyst Emily Field from Barclays describes the market share decline of Novo Nordisk as a 'slow-motion car crash'.
У «Оземпика» появился серьезный конкурент. Американцы уже чаще покупают именно этот препарат для похудения
Emily Field, an analyst at Barclays, commented on the situation regarding the medications.
Index - Tudomány - Súlyos szembetegséget okozhat az egyik legnépszerűbb fogyókúrás csodaszerEmily Field is the head of European pharmaceutical equity research at Barclays who expressed concerns about tariffs on prescription drugs.
Bodo carine zvišale cene zdravil ali pa se bodo farmacevti iz EU preselili v ZDA

